Skip to main navigation Skip to search Skip to main content

CMV and Immunosenescence: From basics to clinics

  • Rafael Solana*
  • , Raquel Tarazona
  • , Allison E. Aiello
  • , Arne N. Akbar
  • , Victor Appay
  • , Mark Beswick
  • , Jos A. Bosch
  • , Carmen Campos
  • , Sara Cantisán
  • , Luka Cicin-Sain
  • , Evelyna Derhovanessian
  • , Sara Ferrando-Martínez
  • , Daniela Frasca
  • , Tamas Fulöp
  • , Sheila Govind
  • , Beatrix Grubeck-Loebenstein
  • , Ann Hill
  • , Mikko Hurme
  • , Florian Kern
  • , Anis Larbi
  • Miguel López-Botet, Andrea B. Maier, Janet E. McElhaney, Paul Moss, Elissaveta Naumova, Janko Nikolich-Zugich, Alejandra Pera, Jerrald L. Rector, Natalie Riddell, Beatriz Sanchez-Correa, Paolo Sansoni, Delphine Sauce, Rene van Lier, George C. Wang, Mark R. Wills, Maciej Zieliński, Graham Pawelec
*Corresponding author for this work
  • Hospital Universitario Reina Sofía
  • University of Extremadura
  • University of Michigan, Ann Arbor
  • University College London
  • Institut national de la santé et de la recherche médicale
  • University of Birmingham
  • Helmholtz Centre for Infection Research
  • University of Tübingen
  • Hospital General Universitario Gregorio Marañon
  • University of Miami
  • Research Center on Aging
  • Cranfield University
  • University of Innsbruck
  • Oregon Health and Science University
  • Tampere University
  • Brighton and Sussex Medical School
  • Agency for Science, Technology and Research, Singapore
  • Pompeu Fabra University
  • Leiden University
  • University of British Columbia
  • Medical University Sofia
  • University of Arizona
  • University of Parma
  • Johns Hopkins University
  • University of Cambridge
  • Medical University of Gdańsk

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates " immunosenescence" . This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop.

Original languageEnglish
Article number23
JournalImmunity and Ageing
Volume9
DOIs
Publication statusPublished - 31 Oct 2012

Fingerprint

Dive into the research topics of 'CMV and Immunosenescence: From basics to clinics'. Together they form a unique fingerprint.

Cite this